Revenue Estimates Analysis of Chimera Investment Corporation(NYSE:CIM) & Cumberland Pharmaceuticals Inc.(NASDAQ:CPIX)

0
9

Chimera Investment Corporation (CIM) will report its next earnings on Feb 13 BMO. The company reported the earnings of $0.6/Share in the last quarter where the estimated EPS by analysts was $0.58/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 3.4%.

Many analysts are providing their Estimated Earnings analysis for Chimera Investment Corporation and for the current quarter 7 analysts have projected that the stock could give an Average Earnings estimate of $0.58/share. These analysts have also projected a Low Estimate of $0.56/share and a High Estimate of $0.61/share.

In case of Revenue Estimates, 6 analysts have provided their consensus Average Revenue Estimates for Chimera Investment Corporation as 150.07 Million. According to these analysts, the Low Revenue Estimate for Chimera Investment Corporation is 144.3 Million and the High Revenue Estimate is 154.9 Million. The company had Year Ago Sales of 157.75 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CIM to be -9.7%. They are projecting Next Quarter growth of -6.9%. For the next 5 years, Chimera Investment Corporation is expecting Growth of -8.62% per annum, whereas in the past 5 years the growth was -0.85% per annum.

Some buy side analysts are also providing their Analysis on Chimera Investment Corporation, where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Chimera Investment Corporation might touch $19 high while the Average Price Target and Low price Target is $18.5 and $18 respectively.

Chimera Investment Corporation closed its last trading session at $19.09 with the loss of -0.26%. The Market Capitalization of the company stands at 3.54 Billion. The Company has 52-week high of $19.32 and 52-week low of $16.27. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 1.56% where SMA50 and SMA200 are 2.36% and 3.28% respectively. The Company Touched its 52-Week High on 12/03/18 and 52-Week Low on 02/09/18.

The Relative Volume of the company is 0.92 and Average Volume (3 months) is 1.35 million. The company’s P/E (price to earnings) ratio is 6.13 and Forward P/E ratio of 8.4.

The company shows its Return on Assets (ROA) value of 2.6%. The Return on Equity (ROE) value stands at 15.7%. While it’s Return on Investment (ROI) value is 2.6%.

While looking at the Stock’s Performance, Chimera Investment Corporation currently shows a Weekly Performance of 0.05%, where Monthly Performance is 5.25%, Quarterly performance is 2.59%, 6 Months performance is 3.87% and yearly performance percentage is 13.67%. Year to Date performance value (YTD perf) value is 6.85%. The Stock currently has a Weekly Volatility of 0.88% and Monthly Volatility of 0.91%.

Cumberland Pharmaceuticals Inc. (CPIX) will report its next earnings on Mar 05 AMC. The company reported the earnings of $-0.05/Share in the last quarter where the estimated EPS by analysts was $-0.19/share. The difference between the expected and actual EPS was $0.14/share, which represents an Earnings surprise of 73.7%.

Many analysts are providing their Estimated Earnings analysis for Cumberland Pharmaceuticals Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.16/share. These analysts have also projected a Low Estimate of $-0.16/share and a High Estimate of $-0.16/share.

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Cumberland Pharmaceuticals Inc. might touch $10 high while the Average Price Target and Low price Target is $10 and $10 respectively.

Cumberland Pharmaceuticals Inc. closed its last trading session at $6 with the loss of -0.5%. The Market Capitalization of the company stands at 95.94 Million. The Company has 52-week high of $7.29 and 52-week low of $5.03. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 3.42% where SMA50 and SMA200 are -1.38% and -0.16% respectively. The Company Touched its 52-Week High on 04/18/18 and 52-Week Low on 02/04/19.

The Relative Volume of the company is 0.1 and Average Volume (3 months) is 8.41 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -6.1%. The Return on Equity (ROE) value stands at -9.1%. While it’s Return on Investment (ROI) value is -11.3%.

While looking at the Stock’s Performance, Cumberland Pharmaceuticals Inc. currently shows a Weekly Performance of 8.46%, where Monthly Performance is -2.29%, Quarterly performance is 12.43%, 6 Months performance is 3.83% and yearly performance percentage is -13.48%. Year to Date performance value (YTD perf) value is -1%. The Stock currently has a Weekly Volatility of 8.44% and Monthly Volatility of 6.05%.

SHARE